ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

ANALYSIS OF ORAL ANTI-HYPERTENSIVE MEDICATION IN BLOOD PRESSURE ELEVATION AND THEIR OUTCOMES IN PAKISTANI POPULATION

Dr Mariam Iftikhar, Dr Behzad Sarwar, Dr Ujala

Introduction: Asymptomatic elevation of systemic blood pressure is an expected event in a determined percentage of hospitalized patients, taking into account the emotional conditions that occur in disease-related admittance, characterizing hypertensive pseudo emergencies. Objectives of the study: The main objective of the study is to analyze the oral anti-hypertensive medication in blood pressure elevation and their outcomes in Pakistani population. Methodology of the study: This cross sectional study was conducted in Mayo hospital Lahore during April 2018 till September 2018 with the permission of ethical committee of hospital. The data was collected from 200 patients which was suffering from high blood pressure and use oral antihypertensive medication. We defined the presence of a written item in the medical records consenting to the use of oral antihypertensive medication when blood pressure reached a certain level as antihypertensive prescription before elevation of blood pressure. We collect some demographic information regarding age, sex, socio-economic status and history of blood pressure. Results: The data was collected from 200 patients who used antihypertensive medication. Nifedipine was the medication given before elevation of blood pressure in 53 patients and captopril in 25 (4.3%). Clonidine was not prescribed during the study period. In 22 (50.7%) patients, prescription of antihypertensive medication before elevation of blood pressure occurred in the absence of treatment with maintained antihypertensive therapy. There are number of factors which influence on blood pressure levels. Conclusion: In conclusion, the results of the present study show a high frequency of prescription of antihypertensive medication preceding elevation of blood pressure.

FULL TEXT